Author

A. J. Khan

Observed names: A. Khan, Atif Khan

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

OpenAlex ID: A5126250283

Integration of Breast Reconstruction and Radiation: How the Proton–Photon Debate Exposes Methodological Gaps, Analytical Bias, and Lack of Consensus

2026 · George E. Naoum, Alphonse Taghian, et al. · International Journal of Radiation Oncology*Biology*Physics · 2

Abstract GS2-05: Primary Results from the HR+/HER2- Cohort of TBCRC-053 (P-RAD): A Randomized Trial of No, Low, or High Dose Preoperative RADiation with Pembrolizumab and Chemotherapy in Node-Positive, HER2-Negative Breast Cancer

2026 · G. Gupta, A. Y. Ho, et al. · Clinical Cancer Research · 1

Abstract PS2-05-29: Feasibility and outcomes of premastectomy radiation therapy in locally advanced breast cancer

2026 · R. Kiernan, V. Sevilimedu, et al. · Clinical Cancer Research

Abstract PS5-02-25: Homologous Recombination Deficiency is the major determinant of response of Triple-Negative Breast Cancer to Cisplatin+Radiotherapy

2026 · S. N. Powell, A. J. Khan, et al. · Clinical Cancer Research

Abstract RF4-07: Genomic characteristics of de novo HER2-positive metastatic breast cancer

2026 · S. Yazaki, E. Ferraro, et al. · Clinical Cancer Research

Abstract PS5-07-02: NRG-BR008: A phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer (HERO)

2026 · M. P. Mitchell, L. Z. Braunstein, et al. · Clinical Cancer Research

Works count: 6

Citation count: 3

H-index: 1

I10-index: